SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
Article
[키워드] acute respiratory syndrome
airway
Analysis
antibodies
B.1.1.7
B.1.617.1
B.1.617.2
BNT162b2
ChAdOx1
ChAdOx1 vaccine
circulation
cleaved
Compromised
coronavirus
D614G
Delta
delta variant
demonstrated
domain
Effectiveness
Efficacy
exhibited
global pandemic
Health care worker
human airway epithelial
immune evasion
India
individuals
Infection
infection control
less
Lineage
measure
monoclonal antibody
Neutralizing
neutralizing antibody
provide
Pseudotyped virus
reduced
Replication
replication efficiency
residual confounding
SARS-CoV-2
SARS-CoV-2 variant
sensitivity
Serum neutralizing antibody
Spike protein
Spread
syncytium formation
the receptor-binding domain
therapy
titre
Transmission
Vaccine
vaccinee
vaccinees
variant
wild-type
Wuhan-1
[DOI] 10.1038/s41586-021-03944-y PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41586-021-03944-y PMC 바로가기 [Article Type] Article